Clinical Trial Update: A Safety Study of ARRY-403 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study of ARRY-403 in adults with Type 2 diabetes, including trial status and safety observations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ARRY-403

Snippet

Sponsor: Array BioPharma | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED